Quality Reliability Technology (405100) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Jul, 2026Executive summary
Provides reliability testing and analysis services for semiconductors and electronic components, with a focus on high-growth sectors such as mobile, automotive, 5G, AI, and aerospace.
Achieved significant revenue growth in 2024, driven by demand for advanced semiconductor testing and new equipment sales.
Expanded R&D and commercialized proprietary reliability testing equipment, including for AI and 5G semiconductors.
Financial highlights
2024 consolidated revenue: KRW 65.25 billion, up 23% year-over-year.
Operating income: KRW 4.77 billion, up 534% year-over-year.
Net income: KRW 2.86 billion, up 9% year-over-year.
Gross margin improved to 42.5% from 38.6% in 2023.
Cash and cash equivalents at year-end: KRW 30.84 billion.
Outlook and guidance
Anticipates continued growth in reliability testing and equipment sales, supported by expansion in AI, 5G, and automotive sectors.
Plans further R&D investment and new product launches in advanced reliability testing equipment.
Latest events from Quality Reliability Technology
- H1 2026 revenue up 18.8% YoY, net income KRW 3.8B, strong equipment sales growth.405100
Q2 2026 - 2024 H1 revenue reached ₩29.5B with ₩1.4B net income, led by reliability testing services.405100
Q2 2024 - FY2025 revenue rose 5.5% to KRW 68.9B, driven by advanced semiconductor reliability demand.405100
Q4 2025 - 2024 Q3 revenue fell, but operating profit rose on cost controls; R&D and market expansion continue.405100
Q3 2024 - Q1 2026 revenue up 32.7% and net income up 779.7% year-over-year, driven by reliability testing demand.405100
Q1 2026 - 2025 Q3 revenue and profit declined, but R&D investment and equity remain strong.405100
Q3 2025 - Q1 2025 revenue and net income grew on robust semiconductor reliability testing demand.405100
Q1 2025 - H1 2025 revenue reached KRW 32.75B with 17.3% of sales invested in R&D.405100
Q2 2025